|
|
|
| home > white papers > CRSF Label - Child-Resistant Blister Packs With Booklet Label - Faubel & Co. Nachfolger GmbH |
|
|
 WHITE PAPERS |
|
Faubel & Co. Nachfolger GmbH
|
|
CRSF Label - Child-Resistant Blister Packs With Booklet Label
|
|
This case study explains how Faubel was commissioned by a leading global pharmaceutical company to develop a label for an aluminum blister pack with 14 cavities, which was used as part of a multinational clinical trial. This label was intended to both protect infants from erroneous ingestion and facilitate use by seniors.
The project was primarily focused on the functionality of the packaging solution, including with regard to the integrity of the inner soft capsules. Due to different countries participating in the clinical trial, the objective was to achieve certification according to EU standard DIN 14375 and US standard 16 CFR § 1700.20 with the final concept as well as to accommodate more than 20 different languages. Despite the high requirements in terms of function and the standard, Faubel was anxious to provide an efficient packaging concept.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
PerkinElmer Signals Research™ Suite Platform Integrates Scientific Data Silos and Enhances Collaboration for R&D Teams
WALTHAM, Mass. – October 25, 2021– PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its Signals Research™ Suite,
a full cloud based solution, deployed on Amazon Web Services.
More info >> |
|
 |
White Papers |
 |
|
Financial implications of off-site visits in clinical research, perception versus reality
Illingworth Research
The concept of patient centricity is still relatively new within clinical trials. For too long, the most important person in the trial has been overlooked… the patient. Here, we explore the benefits of conducting a more patient-centric trial for the patient, site and sponsor through mobile, or ‘off -site’ visits. These advantages are much greater than purely financial, although the financial implications of running a more patient-focused clinical trial may previously have deterred some from this approach. Home nursing in clinical trials continues to be thought of as a high value “premium” service, which many sponsors decline in an attempt to remain within budget for the trial. However, is the actual cost of off -site nursing more expensive than the traditional site model?
More info >> |
|
|
|
